Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRK

Merck & Co Inc

Mar 21 • 04:00PM ET

93.11

Dollar change -1.62
Percentage change -1.71	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE JNJ ABBV BMY AMGN LLY REGN GILD VRTX BHC

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IWF VHT

Scroll to Statements

Index	DJIA, S&P 500	P/E	13.83	EPS (ttm)	6.73	Insider Own	0.09%	Shs Outstand	2.53B	Perf Week	-1.54%
Market Cap	235.20B	Forward P/E	9.43	EPS next Y	9.87	Insider Trans	0.04%	Shs Float	2.52B	Perf Month	6.19%
Income	17.12B	PEG	1.09	EPS next Q	2.13	Inst Own	80.23%	Short Float	1.62%	Perf Quarter	-6.95%
Sales	63.97B	P/S	3.68	EPS this Y	17.35%	Inst Trans	1.39%	Short Ratio	2.88	Perf Half Y	-21.52%
Book/sh	18.32	P/B	5.08	EPS next Y	9.98%	ROA	15.30%	Short Interest	40.94M	Perf Year	-23.81%
Cash/sh	5.45	P/C	17.09	EPS next 5Y	12.66%	ROE	40.81%	52W Range	81.04 - 134.63	Perf YTD	-6.40%
Dividend Est.	3.29 (3.53%)	P/FCF	13.00	EPS past 5Y	12.04%	ROI	20.96%	52W High	-30.84%	Beta	0.40
Dividend TTM	3.16 (3.39%)	Quick Ratio	1.15	Sales past 5Y	7.14%	Gross Margin	74.68%	52W Low	14.89%	ATR (14)	2.14
Dividend Ex-Date	Mar 17, 2025	Current Ratio	1.36	EPS Y/Y TTM	4577.79%	Oper. Margin	33.37%	RSI (14)	49.70	Volatility	1.85% 2.38%
Employees	75000	Debt/Eq	0.83	Sales Y/Y TTM	6.85%	Profit Margin	26.76%	Recom	1.81	Target Price	113.89
Option/Short	Yes / Yes	LT Debt/Eq	0.76	EPS Q/Q	404.83%	Payout	46.32%	Rel Volume	4.80	Prev Close	94.73
Sales Surprise	0.91%	EPS Surprise	6.88%	Sales Q/Q	7.60%	Earnings	Feb 04 BMO	Avg Volume	14.23M	Price	93.11
SMA20	-0.23%	SMA50	-0.27%	SMA200	-13.82%	Trades		Volume	68,222,741	Change	-1.71%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115
Mar-06-23	Initiated	Jefferies	Buy	$125
Feb-22-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$127

Show Previous Ratings

Today 04:35PM	Merck & Co. (MRK): Among Stocks Insiders Were Piling Into Recently (Insider Monkey)
04:04PM	2 Beaten-Down Stocks to Buy on the Dip (Motley Fool)
01:40AM	The Davenport Balanced Income Fund Q4 2024 Commentary (SeekingAlpha)
Mar-21-25 03:41PM	MDPL: No Reason To Pay Those Hefty Fees For Now (SeekingAlpha)
12:20PM	The Davenport Value & Income Fund Q4 2024 Commentary (SeekingAlpha)
09:30AM	Loading…
09:30AM	3 of Goldman Sachs' best investing tips for currently volatile markets (Yahoo Finance)
08:28AM	J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease (Zacks)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
Mar-20-25 05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
11:26AM	Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now (InsiderMonkey)
Mar-19-25 05:50PM	Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
10:45AM	Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In (Insider Monkey)
10:11AM	Merck Loses Almost $52B in 6 Months: How to Play MRK Stock (Zacks)
08:11AM	Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination (TipRanks)
07:00AM	Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy (PR Newswire)
06:45AM	Loading…
06:45AM	Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease (Business Wire)
Mar-18-25 03:18PM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
08:46AM	Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now? (Insider Monkey)
Mar-17-25 03:32PM	Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now? (Insider Monkey)
Mar-16-25 01:06PM	Merck & Co., Inc. (MRK): Among Top Dividend Contenders List (Insider Monkey)
Mar-13-25 08:49AM	MSD to push for approval of HIV combo after Phase III success (Clinical Trials Arena)
Mar-12-25 02:32PM	Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds (Insider Monkey)
01:30PM	Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025 (Benzinga)
11:26AM	Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48 (Business Wire)
10:11AM	Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy (Insider Monkey)
Mar-11-25 08:15AM	Merck opens $1B vaccine plant in North Carolina (BioPharma Dive)
06:45AM	Merck Unveils New Facility to Increase Vaccine Production Capacity (Business Wire)
04:22AM	Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now (Insider Monkey)
Mar-10-25 10:00PM	Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside (Benzinga)
04:40PM	Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds (Insider Monkey)
02:17PM	Loading…
02:17PM	Stock market sell-off: Why these stocks are in the green amid the pain (Yahoo Finance)
Mar-09-25 04:45PM	Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts? (Insider Monkey)
Mar-08-25 03:52PM	Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now (Insider Monkey)
11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
Mar-07-25 05:53AM	Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK (PR Newswire)
Mar-06-25 02:32PM	Merck & Co. (MRK): Among the Best Undervalued Stocks to Invest In Now (Insider Monkey)
11:31AM	Merck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-05-25 03:57PM	Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts (Insider Monkey)
02:42PM	New Version of Mercks Blockbuster Cancer Drug Threatened by Patent Battle (The Wall Street Journal)
06:04AM	Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now? (Insider Monkey)
Mar-04-25 03:59PM	Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025 (Insider Monkey)
11:41AM	Is Merck & Co., Inc. (MRK) the Best Dividend Stock to Buy According to Billionaires? (Insider Monkey)
01:00AM	Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda (BioPharma Dive)
Mar-02-25 02:08PM	Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-28-25 12:35PM	Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025? (Insider Monkey)
09:01AM	Q4 2024 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-25 08:37AM	Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-26-25 03:50PM	Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds? (Insider Monkey)
10:15AM	Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income (Benzinga)
09:45AM	Merck & Co., Inc. (MRK): Among Bourgeon Capitals Top Stock Picks (Insider Monkey)
03:00AM	Cancer vaccines have stumbled, but the approach is gaining new steam (Pharma Voice)
02:00AM	Eikon raises $351M in one of the years largest biotech venture rounds (BioPharma Dive)
Feb-25-25 11:35AM	Jim Cramer Says Merck & Co., Inc. (MRK) Is Maybe The Ultimate Laggard (Insider Monkey)
09:30AM	Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest? (Zacks)
06:45AM	FDA Grants Priority Review to Merck's Application for KEYTRUDA (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (Business Wire)
Feb-24-25 06:45AM	Merck to Participate in the TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-23-25 09:08AM	Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts (Insider Monkey)
Feb-22-25 11:55AM	Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently (Insider Monkey)
Feb-21-25 08:00AM	2 Healthcare Stocks with Big Upside and 1 to Skip (StockStory)
05:45AM	Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRK (PR Newswire)
Feb-18-25 03:55PM	Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now (Insider Monkey)
01:27PM	Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now? (Insider Monkey)
12:00PM	Europe Approves Merck's Cancer Drug For Two Indications (Benzinga)
06:56AM	Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now (Insider Monkey)
06:45AM	WELIREG (belzutifan) Receives First European Commission Approval for Two Indications (Business Wire)
05:45AM	Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK (PR Newswire)
Feb-16-25 08:57PM	Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024? (Insider Monkey)
Feb-15-25 01:30PM	Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes (Insider Monkey)
Feb-13-25 03:54PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
09:00AM	Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:13AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
Feb-12-25 09:00PM	US pharma giant Merck backs healthcare marketplace HD in Southeast Asia (TechCrunch)
01:27PM	Why Merck & Co., Inc. (MRK) is Declining (Insider Monkey)
Feb-11-25 10:42AM	Jim Cramer on Merck & Co., Inc. (MRK): Drug Stocks Are Really Getting Hurt (Insider Monkey)
07:00AM	Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery (PR Newswire)
02:27AM	In the crowded cardio space, its David vs. Goliath for small biotechs (Pharma Voice)
Feb-10-25 06:02PM	Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns (Insider Monkey)
09:04AM	TD Cowen cuts Merck stock to hold on uncertainty around Keytruda, Gardasil (Investing.com)
Feb-09-25 03:03PM	Merck & Co. (MRK): 'Forget It It's China,' Jim Cramer on Vaccine Rollout Woes (Insider Monkey)
Feb-08-25 05:34AM	Is Merck & Co., Inc. (MRK) the Best Dividend Stock According to Wall Street Analysts? (Insider Monkey)
Feb-06-25 06:45AM	Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (Business Wire)
05:07AM	With uncertainty roiling Big Pharma, execs are placing lower-risk bets (Pharma Voice)
Feb-05-25 05:10PM	Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold? (Insider Monkey)
01:25PM	Analysts Defend Merck Amid Investor Concerns Over Weak Guidance (Benzinga)
08:45AM	Evaxion Biotech price target lowered to $6 from $35 at Lake Street (TipRanks)
08:06AM	Why Merck & Co. Inc. (MRK) Went Down on Tuesday (Insider Monkey)
07:00AM	Merck Is Suffering From a Classic Pharma Problem (The Wall Street Journal)
06:39AM	Big Pharma is staying quiet on Trump's China tariffs (Quartz)
02:08AM	Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ... (GuruFocus.com)
01:31AM	Q4 2024 Merck & Co Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-04-25 04:14PM	Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares (Investor's Business Daily) -9.07%
03:15PM	Merck (MRK) Q4 2024 Earnings Call Transcript (Motley Fool)
03:01PM	Merck Stock Plunges 9.5% After China Halt--Is This the Beginning of Bigger Trouble? (GuruFocus.com)
02:38PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
12:40PM	Estée Lauder job cuts, Merck guidance, PepsiCo: Market Minute (Yahoo Finance Video)
12:36PM	Pfizer, Merck Q4 earnings: A breakdown of the pharma stocks (Yahoo Finance Video)
12:28PM	Why Merck (MRK) Stock Is Falling Today (StockStory)
10:47AM	Merck sinks 10% as company halts Gardasil shipments to China, weighing on outlook (Investing.com)
10:38AM	Merck Shares Hit After Guidance Falls Short, Gardasil Challenge (The Wall Street Journal)
09:17AM	Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China (Associated Press Finance)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM
THULIN INGE G	Director	Feb 06 '25	Buy	88.25	2,833	250,000	2,933	Feb 07 04:09 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Feb 06 '25	Sale	88.76	2,361	209,551	7,085	Feb 07 04:07 PM
BAKER DOUGLAS M JR	Director	Feb 05 '25	Buy	88.50	15,000	1,327,500	16,000	Feb 07 04:04 PM
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM
Guindo Chirfi	Chief Marketing Officer	Aug 05 '24	Option Exercise	115.20	36,901	4,250,995	57,782	Aug 06 12:20 PM
Smart Dalton	SVP Fin. - Global Controller	May 03 '24	Option Exercise	128.26	2,046	262,420	4,708	May 06 04:10 PM
Smart Dalton	SVP Fin. - Global Controller	May 04 '24	Option Exercise	127.51	612	78,036	4,730	May 06 04:10 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	May 04 '24	Option Exercise	127.51	27,126	3,458,836	163,720	May 06 04:08 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 04 '24	Option Exercise	127.51	887	113,101	24,058	May 06 04:06 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	May 04 '24	Option Exercise	127.51	912	116,289	24,271	May 06 04:01 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '24	Option Exercise	128.80	2,262	291,346	21,831	May 02 04:29 PM
Smart Dalton	SVP Fin. - Global Controller	May 02 '24	Option Exercise	128.80	381	49,073	3,048	May 02 04:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience